SCHEMBL23313237

SCHEMBL23313237

Cc1nc2cc(OC[C@@H]3C[C@H](F)[C@H](n4cc(-c5cc[nH]n5)c5c(N)ncnc54)O3)ccc2o1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 13/20 0.49
▸ PRMT5 O14744 14/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23313266 0.81 METTL3 (0.60) METTL3PRMT5
SCHEMBL25017607 0.74 METTL3 (0.75) METTL3PRMT5
SCHEMBL25015993 0.74 METTL3 (0.70) METTL3PRMT5
SCHEMBL23313243 0.73 METTL3 (0.57) METTL3PRMT5
SCHEMBL23313158 0.73 PRMT5 (0.82) METTL3PRMT5
SCHEMBL23313247 0.68 PRMT5 (0.62) METTL3PRMT5
SCHEMBL25015586 0.67 PRMT5 (0.73) METTL3PRMT5
SCHEMBL23313248 0.67 PRMT5 (0.57) METTL3PRMT5
SCHEMBL14644481 0.67 ADK (0.43) METTL3PRMT5
SCHEMBL25015953 0.66 METTL3 (0.81) METTL3PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed
Send feedback